These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15596490)

  • 1. Molecular modeling of nearly full-length ErbB2 receptor.
    Bagossi P; Horváth G; Vereb G; Szöllösi J; Tözsér J
    Biophys J; 2005 Feb; 88(2):1354-63. PubMed ID: 15596490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the recognition patterns of the ErbB receptor family transmembrane domains: heterodimerization models through molecular dynamics search.
    Samna Soumana O; Garnier N; Genest M
    Eur Biophys J; 2008 Jul; 37(6):851-64. PubMed ID: 18365190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
    Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
    J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state.
    Bocharov EV; Mineev KS; Volynsky PE; Ermolyuk YS; Tkach EN; Sobol AG; Chupin VV; Kirpichnikov MP; Efremov RG; Arseniev AS
    J Biol Chem; 2008 Mar; 283(11):6950-6. PubMed ID: 18178548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
    Garnier N; Crouzy S; Genest M
    J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization of Neu/Erb2 transmembrane domain is controlled by membrane curvature.
    Khemtémourian L; Buchoux S; Aussenac F; Dufourc EJ
    Eur Biophys J; 2007 Feb; 36(2):107-12. PubMed ID: 17115152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular architecture of the ErbB2 extracellular domain homodimer.
    Hu S; Sun Y; Meng Y; Wang X; Yang W; Fu W; Guo H; Qian W; Hou S; Li B; Rao Z; Lou Z; Guo Y
    Oncotarget; 2015 Jan; 6(3):1695-706. PubMed ID: 25633808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
    Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
    J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.
    Franklin MC; Carey KD; Vajdos FF; Leahy DJ; de Vos AM; Sliwkowski MX
    Cancer Cell; 2004 Apr; 5(4):317-28. PubMed ID: 15093539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study.
    Motamedi Z; Rajabi-Maham H; Azimzadeh Irani M
    J Mol Model; 2021 Nov; 27(12):361. PubMed ID: 34817689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.
    Shih AJ; Telesco SE; Choi SH; Lemmon MA; Radhakrishnan R
    Biochem J; 2011 Jun; 436(2):241-51. PubMed ID: 21426301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between ErbB-1 and ErbB-2 transmembrane domains in bilayer membranes.
    Sharpe S; Barber KR; Grant CW
    FEBS Lett; 2002 May; 519(1-3):103-7. PubMed ID: 12023026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stochastic simulations of ErbB homo and heterodimerisation: potential impacts of receptor conformational state and spatial segregation.
    Hsieh MY; Yang S; Raymond-Stinz MA; Steinberg S; Vlachos DG; Shu W; Wilson B; Edwards JS
    IET Syst Biol; 2008 Sep; 2(5):256-72. PubMed ID: 19045821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational flexibility of the ErbB2 ectodomain and trastuzumab antibody complex as revealed by molecular dynamics and principal component analysis.
    Franco-Gonzalez JF; Cruz VL; Ramos J; Martínez-Salazar J
    J Mol Model; 2013 Mar; 19(3):1227-36. PubMed ID: 23160933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer.
    Aller P; Voiry L; Garnier N; Genest M
    Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains.
    Beevers AJ; Kukol A
    J Mol Graph Model; 2006 Oct; 25(2):226-33. PubMed ID: 16434222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.
    Franco-Gonzalez JF; Ramos J; Cruz VL; Martinez-Salazar J
    J Comput Aided Mol Des; 2014 Nov; 28(11):1093-107. PubMed ID: 25129484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.